Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 510 in Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous NSCLC (LUNG-MAP S1900E)
NCT04625647Phase 2Active, not recruiting
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2021
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of sotorasib in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by SWOG Cancer Research Network. Started Apr 2021; status: active, not recruiting.
02
Drugs
sotorasib
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT04625647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04625647.